News on Salvi%2C Schostok %26 Pritchard P.C. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Salvi%2C Schostok %26 Pritchard P.C. news from BioPortfolio.com Wed, 10 Feb 2010 14:32:44 GMT en [Articles] Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990906&HITNO=0&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990906&THISHREF=http://c.moreover.com/click/here.pl%3fz2513485554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990906&HITNO=0&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990906&THISHREF=http://c.moreover.com/click/here.pl%3fz2513485554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLancet Oncology: Pseudomonas Antibody Lands KaloBios Potential $290M Dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891634&HITNO=1&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891634&THISHREF=http://c.moreover.com/click/here.pl%3fz2459807207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891634&HITNO=1&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891634&THISHREF=http://c.moreover.com/click/here.pl%3fz2459807207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: [Articles] Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3868214&HITNO=2&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3868214&THISHREF=http://c.moreover.com/click/here.pl%3fz2447511453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3868214&HITNO=2&MSIZE=3&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Salvi,%20Schostok%20%26%20Pritchard%20P.C.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3868214&THISHREF=http://c.moreover.com/click/here.pl%3fz2447511453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLancet Oncology: